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Abstract
Background: The mammalian esophageal musculature is unique in that it makes a transition from smooth to
skeletal muscle, with most of this process occurring after birth. In order to better understand the mechanisms
that control esophageal musculature development, we investigated the roles in this process of the paired box
transcription factor, PAX7, a principal regulator of skeletal myogenic progenitor cells. Previous studies showed that
Pax7 is important for determining the esophageal muscle composition.
Results: We characterized the postnatal development of the esophageal musculature in Pax7−/− mice by analyzing
morphology, muscle composition, and the expression of markers of myogenesis, cell proliferation, and apoptosis.
Pax7−/− mice displayed megaesophagus with a severe defect in the postnatal developmental process whereby
esophageal smooth muscle is replaced by skeletal muscle. Pax7−/− esophagi have substantially reduced skeletal
muscle, most likely due to diminished proliferation and premature differentiation of skeletal muscle precursor cells.
This impaired the proximal-to-distal progression of skeletal myogenesis and indirectly affected the patterning of the
smooth muscle-containing portion of the esophageal musculature.
Conclusions: Postnatal patterning of the esophageal musculature appears to require robust, PAX7-dependent cell
proliferation to drive the proximal-to-distal progression of skeletal myogenesis. This process in turn influences distal
smooth muscle morphogenesis and development of the mature pattern of the esophageal musculature.
Keywords: Esophageal myogenesis, Megaesophagus, Pax7, Skeletal muscle, Smooth muscle, Cell proliferation,
Frontal expansion
Background
The musculature of the esophagus controls passage of
food into the stomach by waves of peristaltic contrac-
tions. The lower esophageal sphincter (LES) is a bundle
of smooth muscles at the distal end of the esophagus,
where it meets the stomach. During swallowing, tonic
smooth muscles of the LES relax briefly in order to
allow passage of food into the stomach [1]. Esophageal
muscles are adversely affected in a number of human
disorders, including myotonic dystrophy, oculopharyn-
geal muscular dystrophy, and the inflammatory myop-
athies; this may lead to dysphagia, regurgitation, choking
while eating, and other symptoms. Disorders of LES
function include gastroesophageal reflux disease (GERD)
and achalasia, the latter characterized by impaired relax-
ation of the LES and perturbed peristalsis, often resulting
in megaesophagus. The primary cause of achalasia is de-
fective signaling between the NO-producing inhibitory
myenteric neurons and neighboring smooth muscle cells
(SMCs) of the LES [2, 3]. Although studies have identified
several mutant mouse lines that display these esophageal
defects, their etiologies are poorly understood.
The mammalian esophageal musculature is unique in
that it makes a transition from smooth to skeletal
muscle, with most of this process occurring after birth.
The esophagus is ensheathed by the muscularis externa
(ME) [1, 4, 5]. Skeletal muscle comprises the proximal
portion of the ME and is critical for swallowing and
proximal waves of peristalsis. Smooth muscle surrounds
the distal portion, including the esophagogastric junc-
tion, which harbors the LES. During mammalian devel-
opment, the ME initially comprises only smooth muscle.
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In the mouse, skeletal muscle precursors are first de-
tected in the proximal ME at embryonic day (E) 13 [6].
Over the next 3 weeks of life, smooth muscle is replaced
by skeletal muscle in a proximal-to-distal manner, and
the adult ME pattern is nearly completed by postnatal
day (P) 14 [7–9]. Human esophageal myogenesis is simi-
lar, although smooth muscle is maintained in a more
proximal position than in the mouse, but is still re-
stricted to the distal one-third of the esophagus [10].
Interestingly, the amount and distribution of skeletal
muscle varies among individuals [11, 12]. The develop-
mental and cell biological mechanisms that underlie the
smooth to skeletal muscle replacement process have
been controversial, with multiple mechanisms proposed
[7–9, 13–15] (reviewed in ref. [13]). Rishniw et al. [9] were
the first to suggest that some sort of distal compaction of
smooth muscle cells was important in the replacement of
smooth muscle with skeletal muscle. However, the mecha-
nisms for this process remained unclear.
Our previous study provided insight into mechanisms
that control morphogenesis of the esophageal ME [13].
We showed that mice lacking the multifunctional cell
surface receptor Cdo (also called Cdon) have a defect in
the postnatal developmental process whereby esophageal
smooth muscle is replaced by skeletal muscle. Analyses
of various skeletal myogenic markers revealed that pro-
liferative skeletal muscle progenitor cells migrated in a
transition zone (TZ) along the length of the esophagus
in a proximal-to-distal manner, leaving differentiated
myofibers in its wake. Distal to the TZ, smooth muscle
fascicles underwent a morphogenetic process whereby
they changed their orientation relative to each other and to
the lumen. In a distal-to-proximal manner, smooth muscle
fascicles altered their orientation from parallel to the lumen
to nearly perpendicular to the lumen. Upon completion of
the process, smooth muscle occupied only the most distal
part of the esophagus and the LES. Cdo−/− mice had no de-
fect in skeletal myogenesis or in the numbers of various
skeletal muscle progenitor cell types in the TZ. Rather, they
were specifically defective in SMC fascicular reorientation,
leading to ectopic, proximal fascicles displaying an inappro-
priate orientation and an aberrantly proximal skeletal-
smooth muscle boundary [13]. Importantly, Cdo−/− mice
also displayed megaesophagus and achalasia, with a smooth
muscle cell-intrinsic defect in NO-mediated LES relaxation.
Taken together, our previous findings identified a mechan-
ism of ME maturation and provided a link between esopha-
geal morphogenesis and motility disorders. Although the
ME maturation defect in Cdo−/− mice is almost certainly
smooth muscle cell-autonomous, a role for TZ-based skel-
etal myogenesis in promoting the fascicular reorientation
process seems likely.
Multiple mechanisms have also been proposed for
the developmental origin of esophageal skeletal muscles
(ESMs). Minchin et al. reported that, similar to trunk
and limb muscles, ESMs arise from Pax3/Pax7-express-
ing cells that originate in somites [16]. However, Gopa-
lakrishnan et al. have recently demonstrated that ESMs
are derived from the cardiopharyngeal mesoderm, and
their development is dependent on expression of Tbx1
and Isl1, genes important for specific muscles of the
head but not the trunk [17]. These factors lie upstream
of the myogenic bHLH factors, MyoD and myogenin,
which promote commitment and differentiation of cells
in the skeletal muscle lineage [18]. Consistent with a
cranial mesoderm origin for ESMs, Pax3 was not
expressed during development of these muscles and
was dispensable for their development in mice [17].
In contrast to Pax3, Pax7 is expressed in skeletal
muscle precursors of the esophageal TZ [13, 19–22]. Im-
portantly, however, Pax7 is never expressed in the SMC
lineage as shown by lineage tracing studies, immuno-
chemistry, and in situ hybridization [13, 19–22]. Worl et
al. used electron microscopy to show that Pax7−/− mice
had a reduced number of skeletal muscle precursor cells
in the esophageal ME, defective esophageal skeletal myo-
genesis, and an aberrantly proximal skeletal-smooth
muscle boundary [14]. As Pax7 is not expressed in the
smooth muscle lineage, such mice offer an opportunity
to ask whether TZ-based skeletal myogenesis might
affect smooth muscle patterning in the esophagus. We
report here that Pax7−/− mice have a severe defect in the
postnatal developmental process whereby esophageal
smooth muscle is replaced by skeletal muscle. Our re-
sults suggest that this defect is due to reduced cell pro-
liferation in the TZ, probably due to precocious
differentiation of skeletal muscle precursor cells, leading
to a deficit in skeletal muscle. This defect in Pax7−/−
mice is associated with both megaesophagus and defect-
ive maturation of esophageal smooth muscle patterning.
Our findings add to the previous model for esophageal
musculature development. PAX7-dependent cell prolif-
eration in the TZ is important for the proximal-to-distal
progression of esophageal skeletal myogenesis. Further-
more, loss of PAX7 leads to a non-autonomous defect
that influences smooth muscle fascicle reorientation and
development of a mature ME.
Methods
Mice
Pax7+/− mice were originally obtained from Peter Gruss
[20] and are from the colony maintained by the Rudnicki
laboratory. These mice are on a 129Sv background. It
has previously been reported that on a C57BL/6J back-
ground, Pax7+/− esophagi have a mild defect in develop-
ment of the esophageal musculature [14]. On the 129Sv
background, we have not observed differences in esopha-
geal development between Pax7+/+ and Pax7+/− mice, and
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at P21 they were indistinguishable in esophageal length,
location of the skeletal-smooth muscle boundary, and lu-
minal diameter (Additional file 1: Figure S1). Therefore,
we used both Pax7+/+ and Pax7+/− animals as controls.
All animal procedures were conducted in accordance with
institutional guidelines for the care and use of laboratory
animals as approved by the Institutional Animal Care and
Use Committees (IACUC) of the Icahn School of
Medicine at Mount Sinai and according to the Canadian
Council on Animal Care guidelines and the University of
Ottawa Animal Care Committee protocols.
Preparation of frozen sections
Dissected esophagi were prepared for histology by dir-
ectly freezing in OCT. For longitudinal sections, inci-
sions were made along the entire esophagus in order to
clear out the ingesta, and the sheet of dissected esopha-
gus was laid flat prior to freezing. Frozen tissue blocks
were sectioned at 10 μm and placed on Superfrost Plus
slides (Thermo Fisher Scientific).
Immunofluorescence and histology
Frozen sections (10 μm) were immunostained as previously
described [13]. Slides were fixed in 4 % PFA, washed in
PBS, permeabilized in 0.3 % Triton/PBS, washed in PBS,
blocked in 10 % goat serum, and incubated overnight
at 4 °C with primary antibodies in blocking buffer.
Additional M.O.M. blocking (Vector Laboratories) steps
were performed according to the manufacturer’s instruc-
tions when mouse primary antibodies were used. Anti-
bodies used included mouse anti-sarcomeric actin (5C5;
1:1000; Sigma-Aldrich), rabbit anti–α-smooth muscle
actin (1:200; Abcam), rabbit anti-MyoD (1:500; Santa
Cruz Biotechnology, Inc.), mouse anti-myogenin (F5D;
1:50; Santa Cruz Biotechnology, Inc.), mouse anti-M-
cadherin (1:75; Santa Cruz Biotechnology, Inc.), rabbit anti-
nNOS (C12H1; 1:500; Cell Signaling Technology), rabbit
anti-Ki67 (1:1000; Leica), mouse anti-Ki67 (1:100; BD
Pharmingen), and rabbit anti-phospho-Histone H3 (ser10)
(1:1000; Millipore). After permeabilization, the following
antibodies required an antigen retrieval step of boiling the
sections in 10 mM sodium citrate: mouse anti-Pax7
(1:100; Developmental Studies Hybridoma Bank, Iowa
City, IA), and rabbit cleaved caspase-3 (Asp175; 1:1000;
Cell Signaling Technology). Fluorescent secondary anti-
bodies were from Invitrogen and used at 1:1000: goat anti-
rabbit Alexa Fluor 488, anti-rabbit Alexa Fluor 568, goat
anti-mouse Alexa Fluor 488, and goat anti-mouse IgG1
Alexa Fluor 647. Nuclei were fluorescently labeled with
DAPI and mounted with Fluoromount-G anti-fade
medium (SouthernBiotech). TUNEL assay was performed
using the In Situ Cell Death Detection kit from Roche. For
Figs. 4 and 5 and Additional file 2: S2, the transition zone
was identified by adjacent longitudinal sections stained with
antibodies to 〈-smooth muscle actin and sarcomeric actin.
Hematoxylin and eosin (H&E) staining was performed
as described [23]. Sections were dehydrated through
graded ethanol and xylene and mounted with Permount
(Fisher Scientific).
Microscopy
Microscopy was performed at the Mount Sinai Microscopy
Shared Resource Facility using Axioplan2 and Axioplan2 IE
microscopes (Carl Zeiss) equipped with ×10, ×20, ×40, and
×100 objective lenses that had numerical apertures of 0.5,
0.8, 0.75, and 1.4, respectively. Images were acquired at
room temperature with a camera (Axio Cam MRm; Carl
Zeiss). Mosaic images were compiled using the stitching
feature in the AxioVision software. The maximum luminal
diameter and length of esophageal skeletal/smooth muscle
were measured by using ImageJ software (National
Institutes of Health).
Statistical analysis
Data were expressed as mean ± standard deviation. Differ-
ences were tested by two-tailed t test. Values with P < 0.05
were considered statistically significant.
Results
Pax7−/− mice develop megaesophagus
Most Pax7−/− mice die within 3 weeks of birth [20]. Sur-
viving P21 Pax7−/− mice displayed megaesophagus with
100 % penetrance. P21 Pax7−/− esophagi had an enlarged
diameter relative to Pax7+/+ and Pax7+/− esophagi, and a
dilated lumen filled with partially digested food (Fig. 1a–d).
No other gross abnormalities were observed in the GI
tracts of Pax7−/− mice. P21 Pax7+/− esophagi resembled the
wild type in esophageal length, location of the
skeletal-smooth muscle boundary, and luminal diam-
eter (Additional file 1: Figure S1); therefore, Pax7+/+
and Pax7+/− esophagi were used interchangeably as con-
trols. Immunofluorescence analysis (IFA) of longitudinal
sections of P21 esophagi with markers of smooth muscle
(α-smooth muscle actin (αSMA)) and skeletal muscle
(sarcomeric actin (SA)) revealed that Pax7−/− mice have a
mispatterned ME, with the skeletal-smooth muscle
boundary occurring at an abnormally proximal position
(Fig. 1c, d). Most smooth muscle in the esophagi of
Pax7+/− mice was found in a short, broad segment at
the esophagogastric junction, where SMCs were bun-
dled into fascicles that were stacked side by side with
an orientation perpendicular to the lumen (Fig. 1i). In
contrast, distal to the aberrantly proximal boundary
in Pax7−/− esophagi, there was a long, thin, ectopic
extension of smooth muscle that connected to the
LES (Fig. 1d, j). The fascicles in this ectopic region of
smooth muscle in Pax7−/− esophagi were parallel to the
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lumen, indicating they had failed to undergo the normal
reorientation process. A few SMCs were dispersed within
the skeletal muscle at the skeletal-smooth muscle bound-
ary in both Pax7+/− and Pax7−/− esophagi (Fig. 1g, h).
Despite the mispatterned and thinner ME distal to the ab-
errantly proximal boundary in Pax7−/− esophagi, the
morphology of the smooth muscle fascicles appeared nor-
mal in the Pax7−/− LES (Fig. 1k, l). The Pax7−/− LES was
Fig. 1 Pax7−/− mice have megaesophagus. a, b P21 Pax7+/− and Pax7−/− esophagi. c–j Longitudinal sections of P21 Pax7+/− and Pax7−/− esophagi
were stained with antibodies to α-smooth muscle actin (αSMA; red) and sarcomeric actin (SA; green) for smooth and skeletal muscles, respectively.
c, d Pax7−/− esophagi have an aberrantly proximally located skeletal-smooth muscle boundary (arrows). Note that the Pax7+/+ esophagus is cut
off at the top end, making it appear shorter than the Pax7−/− esophagus, the full length of which is shown. In fact, at P21, Pax7−/− esophagi are
shorter than Pax7+/+ esophagi (see Fig. 3e). e, f The proximal ME of Pax7−/− esophagi has skeletal muscle of relatively normal appearance. g, h
Smooth muscle cells are dispersed with skeletal myofibers around the skeletal-smooth muscle boundary (Boundary). Note that the ME of the Pax7−/−
esophagus is thinner than the control at the skeletal-smooth muscle boundary. i, j The distal Pax7−/− esophagus has a long, thin extension of smooth
muscle instead of the short, broad segment of smooth muscle found in controls. e–j The thin αSMA+ layer adjacent to the ME is the muscularis
mucosa (arrowheads). k, l Longitudinal sections through the LES of P21 Pax7+/+ and Pax7−/− esophagi mice were stained with antibodies to αSMA
(green) and nNOS (red) to label inhibitory intramural neurons. m Quantification of the relative numbers of nNOS+ cells to αSMA staining in the ME of
the LES. Values are means ± SD, n = 5. Bars: (c, d) 1 mm; (e–l) 0.2 mm
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somewhat thinner than that of the control mice (con-
trol = 135.8 ± 9.6 mm (n = 5); mutant = 92.0 ± 12.9 mm
(n = 6); p < 0.01). This may be due to a combination
of defective development of the ME and the overall
growth retardation displayed by these mice [20]. The
ME of the proximal portion of Pax7−/− esophagi was simi-
lar to that of Pax7+/− esophagi, although the skeletal myo-
fibers in mutants appeared to have a greater amount of
between-fiber space than in controls (Fig. 1f).
Megaesophagus is sometimes associated with loss of
nitrergic neurons in the myenteric plexus of the LES [3].
We therefore quantified the number of neurons in the
LES from P21 Pax7+/+ and Pax7−/− mice. IFA of LES
sections with an antibody to nNOS revealed that the
number and pattern of nitrergic neurons were similar
between control and mutant mice (Fig. 1k–m). Taken to-
gether, P21 Pax7−/− mice showed megaesophagus with
an aberrantly proximal skeletal-smooth muscle bound-
ary. The morphological defects of the P21 Pax7−/− ME
were most apparent in the region between the skeletal-
smooth muscle boundary and LES, but were not as se-
vere in the proximal region and in the LES itself.
Defective ME patterning in Pax7−/− esophagi
To determine when these defects in Pax7−/− mice arose,
cross sections were taken from P0-P21 at proximal, mid-
level, and distal regions. Expression of αSMA and SA
was assessed. The proximal and distal ME were com-
posed of skeletal and smooth muscles, respectively, and
the cross sections of proximal and distal Pax7−/− esoph-
agi showed no obvious defects at P0, P7, and P21
(Fig. 2a–f, m–r, s, u). Mid-level cross sections revealed
that esophageal dilation became recognizable in Pax7−/−
esophagi at P7 (Fig. 2g–j, t), and this distention was
more severe at P21 (Fig. 2k, l, t). H&E-stained cross sec-
tions revealed that the P21 Pax7−/− ME was thinner than
that of controls in the mid-level region (Fig. 2v–x). In
contrast to the control mid-level ME, which was com-
posed of skeletal muscle at P7 and P21, the Pax7−/−
mid-level ME displayed only smooth muscle at these
time points (Fig. 2i–l).
These findings are consistent with the aberrant
skeletal-smooth muscle boundary seen in P21 Pax7−/−
esophagi (Fig. 1d), and they suggested a defect in the
process whereby smooth muscle is replaced by skeletal
muscle in these animals. We therefore analyzed the
proximal-to-distal progression of skeletal myogenesis
during ME development. Expression of αSMA and SA
was assessed in longitudinal sections taken at P0, P7,
and P21 (Figs. 1c, d and 3a–d). The distal-most skeletal
muscle cells in these sections were embedded in smooth
muscle. Progression of ME development was monitored
by measuring the distance from the distal-most SA+ cell
to the LES. At P0, this distance was about half of the
length in Pax7+/− esophagi, whereas it constituted nearly
80 % of the total length in Pax7−/− esophagi (Fig. 3a, b, e).
The distance from the distal-most SA+ cell to the LES di-
minished in Pax7+/− esophagi from P0 to P21, and the
distal-most SA+ cell was found just proximal to the LES at
P21 (Figs. 1c and 3a, c, e). In contrast, the distal-most SA+
cell in Pax7−/− animals was at a significantly more prox-
imal location than in Pax7+/− animals as early as P0 and
maintained through P21 (Figs. 1d and 3b, d, e). The dis-
tance from the distal-most SA+ cell to the LES slightly de-
creased in Pax7−/− esophagi by P21; however, the distance
still constituted ~65 % of the total length (Fig. 3e). The
total length of Pax7−/− esophagi is ~20 % shorter than that
of control animals by P21 (Fig. 3e) [14]. This is likely due
to overall growth retardation in these mice [20], but can-
not alone account for the ME patterning defects.
Pax7−/− esophagi have reduced number of cells
undergoing myogenic differentiation
To analyze the Pax7 expression pattern in developing
esophageal ME, longitudinal sections of Pax7+/− esoph-
agi were taken at P7 and P21 and stained with an anti-
body for Pax7. At P7, most Pax7+ cells were found in
the TZ, and their number decreased at more proximal
locations (Fig. 4a, c, e, g). Pax7+ cells diminished from the
entire esophagi at P21, when proximal-to-distal progres-
sion of skeletal muscle was complete (Fig. 4b, d, f, g). At
this stage, relatively few Pax7+ cells were present, as these
probably mainly represent the population of satellite cells
seen in the adult esophagus [13, 24].
We hypothesized that impaired proximal-to-distal pro-
gression of skeletal myogenesis in Pax7−/− esophagi re-
sulted from a decrease in the number of cells undergoing
myogenic differentiation. We therefore assessed the ex-
pression of MyoD (a marker of determined myoblasts)
and myogenin (a marker of differentiating myoblasts) dur-
ing ME development. Longitudinal sections of P7 Pax7+/−
and Pax7−/− esophagi were stained with antibodies for
MyoD and myogenin. Consistent with our previous study
[13], most MyoD+ and myogenin+ cells were found in the
TZ and their numbers diminished at more proximal loca-
tions in control animals. Pax7−/− mice had ~30 % the
number of MyoD+ cells and ~50 % the number of myo-
genin+ cells as control mice (Fig. 5a–f ).
Reduction of the number of cells expressing these
markers of myogenesis may result from a decrease in
the muscle progenitor cell population, either by alter-
ation in cell proliferation or cell survival. To investigate
cell proliferation in the developing ME, longitudinal sec-
tions were taken from P7 Pax7+/− and Pax7−/− esophagi
and stained with antibodies for Ki67 and phospho-histone
H3. Most Ki67+ and phospho-histone H3+ cells were
found in the TZ in Pax7+/− esophagi (Fig. 5g, k, l, p).
Much lower numbers of Ki67+ and phospho-histone H3+
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cells were found in the Pax7−/− TZ (Fig. 5h, k, m, p). Con-
sistent with the largely postmitotic nature of ME smooth
muscle cells [13], fewer Ki67+ and phospho-histone H3+
cells were present in the distal ME below the TZ in both
Pax7+/− and Pax7−/− esophagi (Fig. 5i, j, k, n, o, p). There-
fore, cell proliferation in the TZ is substantially reduced in
Pax7−/− mice.
To confirm that cell proliferation was reduced in skel-
etal muscle precursor cells per se, we stained longitudinal
P7 sections with antibodies for MyoD or another lineage
marker, M-cadherin, plus Ki67. Pax7−/− mice had ~20 %
the number of MyoD+/Ki67+ cells in the TZ as control
mice (Fig. 5q–w). Pax7−/− mice had only ~13 % the num-
ber of M-cadherin+ cells as controls (Fig. 5x–dd). Further-
more, ~45 % of control M-cadherin+ cells were also
positive for Ki67, whereas none of the small number of
M-cadherin+ cells in the Pax7−/− TZ were also positive for
Ki67. These results indicate that cell proliferation of
Fig. 2 Defects in ME patterning in Pax7−/− esophagi. a–r Cross sections of P0, P7, and P21 Pax7+/− and Pax7−/− esophagi were stained with
antibodies to αSMA, SA, and DAPI. j, l The P7 and P21 Pax7−/− esophagi are dilated, and skeletal muscle is replaced by smooth muscle at the
mid-level region (Mid). s–u Luminal diameter at the mid region of Pax7−/− esophagi is larger than that of Pax7+/− esophagi at P7 and P21. Values
are means ± SD, n = 3–11. v, w Cross sections of P7 Pax7+/− and Pax7−/− esophagi at the mid region were stained with H&E. Ep epithelium, MM
muscularis mucosa, ME muscularis externa. The black horizontal bars indicate the width of the ME; the asterisks indicate the lumens. x Quantification
of the width of the ME, as shown in (v and w). Values are means ± SD, n = 3. Bars: (a–r) 0.2 mm, (v, w) 50 μm. **P < 0.01; ***P < 0.001
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skeletal muscle precursors is strongly diminished in the
Pax7−/− esophagus.
We next analyzed longitudinal sections of P7 Pax7+/−
and Pax7−/− esophagi by TUNEL assay and by IFA with
an antibody to cleaved caspase-3, with thymuses as posi-
tive controls. TUNEL+ and cleaved caspase-3+ cells were
easily detected in control thymuses (Additional file 2:
Figure S2E, J). Consistent with previous studies [7–9, 13],
no apoptotic cells were observed in Pax7+/− esophagi
(Additional file 2: Figure S2A, C, F, H). Furthermore, no
TUNEL+ or cleaved caspase-3+ cells were observed in the
esophagi of Pax7−/− mice (Additional file 2: Figure S2B, D,
G, I), indicating that the diminished skeletal myogenesis
seen in these mice is not a consequence of cell death.
Discussion
In this study, we investigated the role of Pax7 in esopha-
geal musculature development. Pax7−/− mice displayed
megaesophagus with a severe defect in the postnatal de-
velopmental processes whereby esophageal smooth
muscle is replaced by skeletal muscle and the ME ac-
quires a mature pattern. The proximal-to-distal progres-
sion of skeletal myogenesis was impaired in Pax7−/−
esophagi, associated with a significant reduction in cell
proliferation of skeletal muscle precursors in the TZ.
Additionally, our findings revealed that Pax7 is import-
ant for proper postnatal patterning of the entire ME, in-
cluding the distal smooth muscle layers.
We previously proposed a model for postnatal devel-
opment of the esophageal ME [13]. During esophageal
ME maturation, skeletal muscle progenitors commit to
the myogenic lineage and differentiate within a TZ that
migrates along the length of the esophagus in a
proximal-to-distal manner. Distal to the TZ, SMCs are
largely non-proliferative and bundled into long, thin fas-
cicles. SMC fascicles are initially arranged end-to-end
and parallel to the lumen. During ME maturation, SMC
fascicles rearrange their orientation such that they are
ultimately arranged side by side and nearly perpendicu-
lar to the lumen; as a consequence, at the end of ME
maturation, the fascicles occupy only the distal portion
of the ME. Fascicular reorientation occurs in a distal-to-
proximal manner. We suggested that this process “clears
Fig. 3 Pax7−/− mice display defective proximal-to-distal progression
of ME development. a–d Longitudinal sections of P0 and P7 Pax7+/−
and Pax7−/− esophagi were stained with antibodies to αSMA, SA,
and DAPI. Pax7−/− esophagi have an aberrantly proximally located
skeletal-smooth muscle boundary (arrows). The SA+ tissue near the
distal end of the Pax7+/− esophagus in (a) is the diaphragm. e The
distance between the distal-most SA+ cell and the LES was measured
and is represented by the red portion of the histogram bars. The
distance decreases progressively with age in Pax7+/− esophagi, but
this fails to occur in Pax7−/− esophagi. Values are means ± SD, n = 3–5.
Bars: 1 mm. ***P < 0.001
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a path” for the TZ, which migrates distally and produces
the skeletal myofibers that constitute the majority of the
length of the mature ME of the adult mouse [13].
Mice lacking the multifunctional cell surface receptor,
Cdo, have a mispatterned ME, including an aberrantly
proximal skeletal-smooth muscle boundary, and they de-
velop megaesophagus. These mice are specifically defect-
ive in SMC fascicular reorientation, without obvious
alterations in TZ-based skeletal myogenesis [13]. Cdo−/−
mice had an ectopic, proximal region of smooth muscle
in which the fascicles remained in the end-to-end,
parallel-to-the-lumen orientation that normally charac-
terizes an earlier developmental stage. This phenotype is
very likely to be SMC-autonomous [13]. In contrast, the
esophageal defects in Pax7−/− mice are almost certainly
autonomous to the skeletal muscle lineage. Pax7 is
expressed in skeletal muscle precursor cells throughout
the body, including the esophageal TZ, but it is never
expressed in the SMC lineage [13, 19–22]. Examination
of esophageal ME patterning in Pax7−/− esophagi re-
vealed that their musculature consisted mainly of
smooth muscle, having skeletal muscle only at the very
proximal end. This phenotype was more severe in Pax7−/−
esophagi than Cdo−/− esophagi. Smooth muscle occupied
the distal ~20 % of P14 Cdo−/− esophagi, whereas it occu-
pied the distal ~65 % of P21 Pax7−/− esophagi. There was
no difference in the position of the skeletal-smooth
muscle boundary between control and Cdo−/− mice at P0,
but Pax7−/− esophagi already had an aberrantly proximal
skeletal-smooth muscle boundary at P0. Moreover, in con-
trast to Cdo−/− mice, the numbers of MyoD+ and myo-
genin+ cells were reduced, as was cell proliferation, in the
Fig. 4 Expression of Pax7 in the esophageal musculature at P7 and P21. a–f Longitudinal sections of P7 and P21 Pax7+/− esophagi were stained
with antibodies to Pax7, laminin, and DAPI. Proximal, mid-level (Mid), and TZ regions were analyzed. The greatest number of Pax7+ cells was
observed in the TZ at P7, and the numbers diminished in mid and proximal regions. The number of Pax7+ cells is diminished at P21 when
proximal-to-distal progression of ME development is complete. g Quantification of Pax7+ cells in proximal (prox), mid, and TZ regions measured
as a percentage of total DAPI+ cells in the ME. Bars: 0.2 mm
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Pax7−/− TZ. Therefore, the aberrantly proximal skeletal-
smooth muscle boundary in Pax7−/− esophagi resulted
from reduced production of ESM.
Distal to the aberrantly proximal skeletal-smooth
muscle boundary, the Pax7−/− smooth muscle layer was
very thin, with the fascicles parallel to the lumen for
Fig. 5 Reduced skeletal muscle precursor cell proliferation in the Pax7−/− TZ. a, b, d, e Longitudinal sections of P7 Pax7+/− and Pax7−/− esophagi
were stained with either MyoD (a, b) or Myogenin (d, e) antibodies and DAPI. The TZ was analyzed. c, f Quantification of MyoD+ (c) and Myogenin+
(d) cells within the TZ, measured as a percentage of total DAPI+ cells in the ME. Values are means ± SD, n = 3–5. g–j, l–o Longitudinal sections of P7
Pax7+/− and Pax7−/− esophagi were stained with either Ki67 (g–j) or phospho-histone H3 (PH3) (l–o) and DAPI. The TZ and distal region were analyzed.
k, p Quantification of Ki67+ (k) and PH3+ (p) cells within the TZ and distal region, measured as a percentage of total DAPI+ cells in the given region.
The numbers of Ki67+ and PH3+ cells were reduced in the TZ in Pax7−/− mice, but not in the distal region. Values are means ± SD, n = 4–5.
q–v Longitudinal sections of P7 Pax7+/− and Pax7−/− esophagi were stained with MyoD and Ki67 antibodies and with DAPI. w Quantification of
MyoD+/Ki67+ cells within the TZ, measured as a percentage of total DAPI+ cells in the TZ. Values are means ± SD, n = 4. x–cc Longitudinal sections of
P7 Pax7+/− and Pax7−/− esophagi were stained with M-cadherin (Mcad) and Ki67 antibodies and with DAPI. dd Quantification of total Mcad+ and
Mcad+/Ki67+ cells within the TZ, measured as a percentage of total DAPI+ cells in the TZ. Values are means ± SD, n = 4. Bars: 0.2 mm (a–v); 20 μm
(x–cc). *P < 0.05; **P < 0.01
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nearly the entire length of the ME. The LES was normally
patterned, consistent with it being in the region in which
fascicles reorient earliest [13]. As Pax7 is never expressed
in the SMC lineage, the mispatterning of ESM in Pax7−/−
esophagi is presumably a non-cell-autonomous effect. It
seems likely that smooth muscle mispatterning occurs as
a consequence of impaired proximal-to-distal progression
of the Pax7−/− TZ, but further work will be required to
prove this. One physiological consequence of this combin-
ation of deficient skeletal myogenesis and SMC fascicle
mispatterning is that Pax7−/− mice have an enlarged lu-
minal diameter specifically in the mid region of the
esophagus (i.e., megaesophagus). We speculate that
smooth muscles, in this abnormal location and fascicular
arrangement, are not successful in maintaining the full in-
tegrity and function of the ME. This may occur for a var-
iety of non-mutually exclusive reasons, including defective
peristalsis, causing the slow passage of food and physical
distension; suboptimal innervation; or some combination
of these and additional processes.
Our findings support and add to the previous model
for esophageal musculature development. Based on the
fact that Pax7−/− mice display a presumably non-SMC-
autonomous defect in fascicular reorientation, we
propose the following hypothesis. Smooth muscle fasci-
cular reorientation may be facilitated by forces exerted
via the proximal-to-distal progression of the TZ. This
progression may “push” the SMCs to a more distal re-
gion, where they are eventually exposed to the signals
that trigger the rearrangement of SMCs relative to one
another, resulting in reorientation of fascicles. Prolifera-
tion of skeletal muscle precursor cells was significantly
reduced in the Pax7−/− TZ during esophageal muscular
development. This suggests that robust cell proliferation,
which presumably participates in driving the proximal-
to-distal progression of the TZ, depends on PAX7. This
is consistent with the known roles of PAX7 in maintain-
ing proliferation and preventing precocious differenti-
ation [24, 25]. Therefore, it is most likely that skeletal
muscle precursor cells differentiate prematurely during
esophageal myogenesis in the Pax7−/− TZ, resulting in
reduced production of ESM.
That robust cell proliferation in the TZ may be critical
for the proximal-to-distal progression of skeletal myo-
genesis is supported by a mathematical model of cell mi-
gration [26]. This model predicts that proliferation at
the invading front is the key mechanism driving directed
migration. These predictions were experimentally vali-
dated with the directional migration and colonization of
the gut by vagal neural crest cells that establish the enteric
nervous system [26]. This “frontal expansion” model,
which emphasizes the importance of proliferation to a car-
rying capacity, is potentially relevant to a wider range of
invasion systems such as angiogenesis, epidermal wound
healing, and malignant invasion [26]. Therefore, this
model may also apply to the proximal-to-distal progres-
sion of esophageal skeletal myogenesis.
Megaesophagus is observed as a feature of several ani-
mal models of Duchenne muscular dystrophy, including
some strains of mdx mice, and some dystrophic dog
and cat models [27–30]. It was proposed that megae-
sophagus in some of these animal models was caused
by a hypertrophic diaphragm and ensuing esophageal
constriction, a very different scenario than that seen
in Pax7−/− mice. There is, however, little in the literature to
suggest that megaesophagus is common in patients with
muscular dystrophy or other myopathies. Megaesophagus
occurs more frequently in severe cases of achalasia, as a
consequence of inability to fully relax the LES [2, 3]. It will
be of interest for future studies to use electrophysiology
and manometry to test if Pax7−/− mice have a non-
autonomous defect in LES function.
Conclusions
Our analyses on Pax7−/− esophageal musculature devel-
opment suggest that ME patterning requires robust,
PAX7-dependent cell proliferation in the TZ, which
helps drive the proximal-to-distal progression of skeletal
myogenesis. This process may in turn be necessary for
distal smooth muscle fascicle reorientation and develop-
ment of a mature ME.
Additional files
Additional file 1: Figure S1. Pax7+/+ and Pax7+/− esophagi have similar
luminal diameter, esophageal length, and location of the skeletal-smooth
muscle boundary. (A) Cross-sections of mid-region (Mid) esophagi from
P21 mice of the indicated genotype were used to quantify luminal diameters.
Values are means ± SD, n = 3. (B) Longitudinal sections of P21 Pax7+/+ and
Pax7+/− esophagi were stained with antibodies to αSMA and SA and with
DAPI. The length of the entire esophagus was measured, as was the location
of the skeletal-smooth muscle boundary. Values are means ± SD, n = 3.
Pax7+/+ and Pax7+/− esophagi were not different in these parameters.
Additional file 2: Figure S2. Lack of apoptosis in control or Pax7−/−
esophageal musculature at P7. (A-D and F-I) Longitudinal sections of P7
Pax7+/− and Pax7−/− esophagi were stained with antibodies to cleaved
caspase 3 (C-caspase 3) (A-D) and DAPI, or for TUNEL+ cells (F-I) and
DAPI. The TZ and distal region were analyzed. Apoptotic cells were not
observed in the esophageal ME. (E and J) Pax7+/− thymuses were used
as a positive control and displayed easily detectable apoptotic cells by
both IFA for cleaved caspase 3 (E) and TUNEL (J). Bars: 0.2 mm.
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